Canada's Top 40 Research Hospitals


Congratulations to RI-MUHC researchers who received Canada Research Chairs!

Fall 2020 competition (2019-2 cycle):

Spring 2020 competition (2019-1 cycle):

  • Shirin Abbasinejad Enger, Canada Research Chair in Medical Physics, CIHR, Tier 2 (New)
  • Stefanie Blain-Moraes, Canada Research Chair in Biosignal Interaction and Personhood Technology, CIHR, Tier 2 (New)
  • David Buckeridge, Canada Research Chair in Population Health Informatics, CIHR, Tier 1 (New)
  • Nada Jabado, Canada Research Chair in Pediatric Oncology, CIHR, Tier 1 (New)
  • Dick Menzies, Canada Research Chair in Tuberculosis Research, CIHR, Tier 1 (New)

We also congratulate two researchers from The Neuro (Montreal Neurological Institute–Hospital) affiliated with the Brain Repair and Integrative Neuroscience (BRaIN) Program at the RI-MUHC:

  • Boris Bernhardt, Canada Research Chair in Cognitive Neuroinformatics of Healthy and Diseased Brains, CIHR, Tier 2 (New)
  • Robert Zatorre, Canada Research Chair in Auditory Cognitive Neuroscience, CIHR, Tier 1 (New)

The Canada Research Chairs Program stands at the centre of a national strategy to make Canada one of the world's top countries in research and development. It invests approximately $295 million per year to attract and retain a diverse cadre of world-class researchers, to reinforce academic research and training excellence in Canadian postsecondary institutions.

Learn more:
Newswire, Social Sciences and Humanities Research Council of Canada, Dec. 16, 2020
McGill Reporter, fall 2020 results
Health E-News, spring 2020 results

—Published Aug. 6, 2020; updated Jan. 15, 2021


Researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) will be conducting 25 new projects designed to accelerate discoveries of benefit to human health, thanks to the Canadian Institutes of Health Research (CIHR) Fall 2019 Project Grants Competition. The RI-MUHC teams received over $16 million in project funding.

Across Canada, the competition has approved 385 research grants and 4 bridge grants for a total investment of approximately $275 million. In addition, over $7 million was awarded for 74 priority announcement bridge grants.

The CIHR Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

Congratulations to RI-MUHC grant recipients and their teams!

Project Grants

  • Faiz Ahmad Khan, Glenda Sandy, Christopher Fletcher, Neil Andersson
    Community Health Workers in Tuberculosis Prevention & Care Services in Nunavik
  • Carolyn Baglole, Ilan Azuelos
    Prognostic and Therapeutic Utility of Human Antigen R (HuR) in Fibrosis
  • Swneke Bailey
    Investigating the Molecular Determinants of Peritoneal Metastasis from Gastro-Esophageal Adenocarcinomas
  • Geneviève Bernard
    Unraveling the molecular basis of novel forms of hypomyelinating leukodystrophies
  • Nancy Braverman
    Developing retinal gene augmentation therapy for Zellweger Spectrum Disorder
  • Pnina Brodt
    Regulatory circuits controlling the immune microenvironment of liver metastases
  • Stella Daskalopoulou
    Early Prediction of preeclampsia Using arteriaL Stiffness in high-risk prEgnancies; a multinational study (PULSE)
  • Samuel David
    Ferroptosis-mediated damage in Chronic EAE: implications for Progressive MS
  • Maziar Divangahi
    Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection
  • Maziar Divangahi
    Reprogramming HSCs to generate protective trained immunity against TB
  • Julio Fiore Jr
    Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis
  • Jacques Genest Jr
    Familial Hypercholesterolemia in Canada: Precision and Personalized Approaches to Increase Identification and Improve Clinical outcomes
  • Wassim Kassouf
    Implication of neutrophil extracellular traps in the efficacy of bladder-sparing therapy in muscle invasive bladder cancer
  • Ivan Litvinov
    Ectopic reactivation of normally silenced germ cell programs contributes to genomic instability, carcinogenesis and cancer progression in Cutaneous T-Cell Lymphomas (CTCL).
  • Monzur Murshed
    Understanding the mechanism of vascular elastocalcinosis and its prevention by MGP
  • Basil Petrof
    Understanding the basis of diaphragmatic weakness in critical illness
  • Giada Sebastiani
    The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
  • Elena Torban
    Actin regulation of ciliogenesis: unraveling novel mechanisms of human ciliopathies caused by mutations in the PCP effector genes
  • Simon Wing
    USP19 in metabolism - mechanisms and translation

Priority announcements

  • Stéphanie Chevalier
    A novel multimodal intervention for surgical prehabilitation of patients with lung cancer
  • Andrey Cybulsky
    Defining the role of ER stress in glomerular disease: identification of new therapeutic and diagnostic targets
  • Maia Kokoeva
    Could mitotic exhaustion of NG2-glia explain the remyelination deficit in MS?
  • Ivan Litvinov
    Prize: Early Career Investigator in Cancer
  • Dan Poenaru
    WeChoose: a mixed-methods study for developing a personalized risk communication tool in pediatric surgery
  • Myriam Srour, Dorothy Barthelemy
    The physiological, molecular and genetic mechanisms underlying lateralization of motor control

Learn more on the Canadian Institutes of Health Research (CIHR) website

—Published January 30, 2020